Search

everythinglearnresearchcommunity

for

Search:↓

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

DPCP is effective for treating severe alopecia areata, but relapse is common.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Triamcinolone regrows hair better but relapses more than anthralin.